A recent class action lawsuit claims that Happy Hippo, LLC failed to disclose the dangers of its kratom products, which are alleged to be as addictive as opioids. The lawsuit highlights serious concerns around consumer awareness and safety in using these products, which many unknowingly believe to be safe herbal supplements. Here’s a look at the key details of this case and what it could mean for consumers.
The proposed class action seeks to cover anyone in the United States who purchased Happy Hippo kratom products, including powders, capsules, and liquid extracts, within the applicable statute of limitations period. This includes customers who bought the products at herbal stores, gas stations, smoke shops, or online.
Kratom is a natural product derived from the leaves of a Southeast Asian tree and is marketed as a herbal supplement. However, kratom’s active compounds, mitragynine and 7-hydroxymitragynine, interact with the brain’s mu-opioid receptors, similar to the way opioids like morphine and heroin do. This interaction, the lawsuit claims, makes kratom highly addictive, with risks of dependency, withdrawal symptoms, and other side effects.
The lawsuit against Happy Hippo alleges several main points:
According to the complaint, many consumers unknowingly became dependent on kratom and were unprepared for the withdrawal symptoms when they tried to stop taking the product.
If successful, this class action lawsuit could lead to financial compensation for affected consumers, potentially covering:
The lawsuit is still in its early stages, and Happy Hippo has not admitted to any wrongdoing. However, the case highlights the importance of transparency in labeling for supplements, especially those with addictive potential. If you or a loved one purchased Happy Hippo kratom products and have experienced dependency or other side effects, consider contacting a class action attorney to learn more about your rights and eligibility to join this lawsuit.
The Happy Hippo Kratom Lawsuit brings awareness to the potential dangers of kratom products and underscores the need for manufacturers to clearly inform consumers about possible risks. By bringing this issue to light, the lawsuit seeks justice for affected consumers and promotes more accurate labeling to prevent future harm.